SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John H. Farro who wrote (575)10/1/1996 7:16:00 PM
From: Richard Mazzarella   of 4342
 
Robin, thanks. I did not see that announcement before and I didn't see anything about AZT in the investors package that I have. AZT was one of the first AIDS drugs if my memory serves me, but HIV became resistant. Maybe the good results were from PN355 alone, the AZT just going along for the ride? I could see a clever marketing ploy in 355 being given with a majors HIV drug as insurance. No FDA approval would be needed.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News